Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Georgios Tsivgoulis
Research Area(s) / Expertise:
Prof Georgios Tsivgoulis M.D., Ph.D., MSc, FESO, FEAN is Professor of Neurology and Vice-Chairman in the Department of Neurology at the National & Kapodistrian University of Athens, School of Medicine in Greece. He is the Divisional Director of Cerebrovascular Diseases, Director of the Neurosonology Laboratory and Director of Residential Training and the Cerebrovascular Fellowship Program. He is… View more
Research Area(s) / Expertise:
Research Area(s) / Expertise:
Sahil Parikh
Research Area(s) / Expertise:

Carotid Artery Disease

Hypertension

 Job title: Director of Endovascular Services and Assistant Professor of Medicine
Dr Sahil Parikh is Director of Endovascular Services and Assistant Professor of Medicine at Columbia University Vagelos College of Physicians & Surgeons in New York. His research interests include coronary artery disease, peripheral arterial disease including claudication, critical limb ischemia, renovascular disease, cerebrovascular disease, venous medicine and thrombosis.Dr Parikh has authored… View more
Research Area(s) / Expertise: Job title: Consultant in the Vascular Surgery Department
ACC 2025: The CardiAMP-HF Trial
Author(s): Amish Raval Added: 1 year ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the… View more

Heart Failure
ACC 25: Optimizing DAPT Duration
Author(s): Hyo-Soo Kim Added: 1 year ago
ACC 25 - Findings from a stratified study investigating coronary stenting and bleeding risk suggest 3 months are the optimal duration of DAPT after PCI.Dr Hyo-Soo Kim (Seoul National University Hospital, KR) sits down to discuss the first randomized study stratifying patients receiving percutaneous coronary intervention with drug eluting stents according to bleeding risk based on the ARC HBR… View more

Anticoagulation

Intervention
Revascularisation in Patients with Cancer
Author(s): Miguel Nobre Menezes , Mamas A Mamas Added: 4 months ago

Intervention

Prevention & Chronic Conditions
2024 ESC Guidelines on Peripheral Arterial and Aortic Diseases
Author(s): Giuseppe Ferrante , Brittany A Bacallao , Francesco Gioia , et al Added: 1 year ago

Vascular Disease and Surgery
Could Acute COVID-19 Infection Ignite Thrombotic Risk?
Author(s): Joshua Stolker , Philippe Gabriel Steg , Roberta Rossini , et al Added: 1 year ago

COVID-19

MI/ACS